JULIO BELARMINO
BOBES GARCIA
Investigador hasta 2022
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (109)
2024
-
Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders
Biological Psychiatry
-
Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation
Schizophrenia Bulletin, Vol. 50, Núm. 2, pp. 327-338
-
Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms
Molecular Psychiatry
2023
-
Basic quality indicators for clinical care of patients with major depression, schizophrenia, and bipolar disorder
Revista de Psiquiatria y Salud Mental
-
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: Results from the EU-GEI case-control study
Psychological Medicine, Vol. 53, Núm. 15, pp. 7375-7384
-
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study
Psychological Medicine, Vol. 53, Núm. 13, pp. 6150-6160
-
Development and Validation of Predictive Model for a Diagnosis of First Episode Psychosis Using the Multinational EU-GEI Case-control Study and Modern Statistical Learning Methods
Schizophrenia Bulletin Open, Vol. 4, Núm. 1
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280
-
Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
Psychiatry Research, Vol. 323
-
Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study
Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106
-
Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders
Psychological Medicine, Vol. 53, Núm. 13, pp. 5986-5991
-
Recent natural selection conferred protection against schizophrenia by non-antagonistic pleiotropy
Scientific Reports, Vol. 13, Núm. 1
-
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study
Psychological medicine, Vol. 53, Núm. 15, pp. 7418-7427
-
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study
Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580
-
Tobacco use in first-episode psychosis, a multinational EU-GEI study
Psychological Medicine, Vol. 53, Núm. 15, pp. 7265-7276
2022
-
A replication study of JTC bias, genetic liability for psychosis and delusional ideation
Psychological Medicine, Vol. 52, Núm. 9, pp. 1777-1783
-
Childhood Maltreatment, Educational Attainment, and IQ: Findings from a Multicentric Case-control Study of First-episode Psychosis (EU-GEI)
Schizophrenia Bulletin, Vol. 48, Núm. 3, pp. 575-589
-
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis
Schizophrenia, Vol. 8, Núm. 1
-
Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway
Psychological Medicine, Vol. 52, Núm. 10, pp. 1910-1922
-
Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113